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BEYOND GIFT AND BARGAIN:
SOME SUGGESTIONS FOR INCREASING
KIDNEY EXCHANGES
NATHAN B. OMAN*
I
INTRODUCTION
Each year, thousands of people in the United States die from end stage renal
disease (ESRD), despite the fact that we have the medical knowledge necessary
to save them. The reason is simple: these people need a kidney transplant and we
have too few kidneys. Given our current technology, the only way to meet the
massive annual shortfall between the number of kidneys that are donated and the
number of kidneys that are necessary to save the lives of those with ESRD is to
increase the number of living donations. The debate on how to do so has often
pitted those who favor creating a “free market” in human organs against those
who believe that the selling of organs by human donors poses unacceptable evils
and risks. Current law prohibits donors from being paid for kidneys. Once the
donation has been made, however, the kidney will often change hands in exchange for money several times before reaching the patient. There are no serious
proposals to ban such transactions.1 This article generally sympathizes with those
who favor the free alienation of kidneys by donors in exchange for payment. The
goal of this article, however, is not to make another charge across the no man’s
land separating free-marketeers from prohibitionists. Rather, it aims to explore
ways in which we can increase trust in order to foster a promising new development in transplant medicine: extended kidney exchange.
Extended kidney exchange is the process by which patients with ESRD who
have a willing donor with an incompatible kidney are paired with others in a similar situation to create a chain of kidney donations that allow all of the patients
to receive a transplant. When donations and transplants occur simultaneously,
extended kidney donations require relatively little trust between participants in

Copyright © 2018 by Nathan B. Oman.
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1. See generally Julia D. Mahoney, The Market for Human Tissue, 86 VA. L. REV. 163 (2000) (discussing the myriad ways in which human tissue changes hands for cash in the United States).
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the otherwise-unrelated donor–patient dyads. However, if exchange of organs
takes place over time, the first-moving donor may be exposed to the risk that a
subsequent donor will renege on her commitment to give a kidney, resulting in
the initial donor’s patient receiving nothing.
The fundamental weakness of simultaneous exchanges is that the chains of
donation are too short to take advantage of every donor who is willing to give a
kidney to an incompatible ESRD patient. Creating longer chains of donation requires that we generate sufficient trust for donors to participate. This article sets
forth two proposals as to how financial incentives could be created that would
assist in the generation of such trust. The first proposal is that participants in extended kidney exchanges obtain a performance bond in the form of a standby
letter of credit from a third party. Bonding, of course, is a well-known practice in
the commercial context. The issuer of a bond, generally in return for a fee, promises to pay a sum of money to an obligee in the event that the obligor—that is the
person who purchased the bond—fails to perform some service. This would likely
require an amendment to current federal law. The second proposal is to further
amend federal law to allow payment of cash incentives to kidney donors in the
very limited situation where such a kidney on the front-end would facilitate a long
chain of life saving donations. As this article will explain in greater detail below,
such non-simultaneous extended altruistic donation (NEAD) involves a single
initial donation in which the donor does not expect to receive a kidney in return.
This means that risk of irreparable injury from nonperformance by the other kidney donors can be eliminated.
The attraction of these two proposals is that while both of them involve financial incentives, neither of them involves a bare sale of organs for cash. The first
proposal is ultimately about providing assurances of fidelity to one’s word. Crucially, no money would change hands between the recipient of the kidney and the
donor of the kidney. Under this proposal, the cost in a successful extended kidney
exchange would be incurred by the donor not the donee. The second proposal
would involve the exchange of a kidney for cash or some other valuable consideration. However, this transaction would be embedded in a much larger set of
exchanges where the motives of the participants, far from being crassly commercial, are usually rooted in affection and altruism. The market transaction’s sole
goal is to leverage the effectiveness of personal generosity. Finally, neither proposal requires the specific performance of a promise to donate a kidney or a lawsuit against a judgment proof individual. In other words, they could provide incentives to participate in extended kidney exchanges without making
unreasonable demands on our legal machinery.
This article proceeds as follows: Part II provides background on the problem
and the policy proposal. It first examines the medical background of kidney donations and organ exchanges. Next, it looks at the normative and legal issues involved in organ exchanges. Part III argues that we can foster trust in non-simultaneous kidney exchanges by allowing donors to post a performance bond in the
form of a standby letter of credit. Part IV shows how changing current law to
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allow payment to organ donors when such donors are the first movers in a NEAD
chain reduces risk in such exchanges and increases trust. Part V concludes.
II
MEDICAL, NORMATIVE, AND LEGAL BACKGROUND OF KIDNEY EXCHANGES
A. Medical Background
Each year tens of thousands of people in the United States suffer from ESRD,
a capacious category that includes diseases, such as diabetes and polycystic kidney disease, that can lead to renal failure.2 Kidneys perform the vital function of
filtering the toxins that naturally accumulate in the blood. Once a patient’s kidneys fail, there are essentially two treatment options. First, patients may go on
dialysis, a process in which they are hooked to a machine for several hours a few
times a week and the machine artificially scrubs their blood of toxins. In addition
to the discomfort and inconvenience that dialysis inflicts upon patients, it is an
imperfect replacement for a properly functioning human kidney. As a result, dialysis is not ultimately a long-term solution for those facing ESRD. While outcomes vary based on a variety of factors, the average life expectancy of the patient on dialysis is roughly five years.3
The second option for those facing ESRD is a kidney transplant, either from
a cadaver or, ideally, from a living donor. Transplant is also not a perfect solution
to the problem of renal failure.4 Some transplants fail when the body rejects the
new organ.5 Those transplants that are successful require a permanent regime of
immunosuppressant drugs to ensure that the body’s own immune system does
not attack the new kidney.6 However, the suppression of the human immune system can lead to its own complications,7 and, regardless, transplanted kidneys do

2. See F. A. DAVIS CO., TABER’S CYCLOPEDIC MEDICAL DICTIONARY 811, 1875 (Donald M. D.
Venes et al. eds., 23d ed. 2017) (defining ESRD and polycystic kidney disease, stating that diabetes and
polycystic kidney disease cause ESRD, and stating that ESRD leads to renal failure).
3. See Philip J. Cook & Kimberly D. Krawiec, A Primer on Kidney Transplation: Anatomy of the
Shortage, 77 LAW & CONTEMP. PROBS., no. 3, 2014, at 1, 7 (“The average life expectancy for a patient
on dialysis is about five years.”).
4. See U.S. DEP’T HEALTH & HUMAN SERVS., UNITED STATES ORGAN TRANSPLANTATION
REPORT: 2012 ANNUAL DATA REPORT 13–14 (2014), available at https://srtr.transplant.hrsa.gov/annual_reports/2012/pdf/01_kidney_13.pdf [https://perma.cc/WAK4-DSHZ] (stating that incidence of
acute rejection among adult kidney transplant patients reaches or exceeds 15% at four years post-surgery).
5. See id.
6. See Gorden Muduma et al., Patient Survey to Identify Reasons for Non-Adherence and Elicitation
of Quality of Life Concepts Associated with Immunosuppressant Therapy in Kidney Transplant Recipients, 10 PATIENT PREFER. ADHERENCE 27, 27–28 (2016) (stating that the life-long nature of immunosuppressant drug regimens for kidney transplant patients contribute to patients not adhering to the regimens).
7. See D. Niethammer et al., Side-Effects of Long-Term Immunosuppression versus Morbidity in
Autologous Atem Cell Rescue: Striking the Balance, 38 RHEUMATOLOGY 747, 748 (1999) (“All immunosuppressive drugs have . . . infections and malignancies” as their main side-effects.).
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not last forever.8 Eventually, if the patient lives long enough, the transplanted
kidney will fail and once more the patient will face dialysis and the search for a
new kidney. Hence, while there is no perfect cure for ESRD, the only option that
offers patients potential long-term survival is a kidney transplant.
The United States faces a chronic shortage of kidneys available for transplant.
In 2012, there were 92,885 people awaiting transplant.9 That number has increased dramatically in recent decades. In 2002, 51,004 people were awaiting
transplant.10 The increase is the natural result of a shortfall of roughly 21,000 kidneys each year.11 One source of organs is donors who agree to donate kidneys in
the event of their death. Successful harvesting from a dead donor, however, requires very specific conditions. The age, health, and manner of the donor’s death
must all be right. Thus, the vast majority of people who die are not candidates to
be cadaverous kidney donors.12 Even if it were logistically and legally possible to
harvest the kidneys of every eligible person who dies in the United States, it
would only increase the supply of kidneys by about 5,500.13 This is because the
United States on the whole already does a fairly good job of making those kidneys available to ESRD patients (and eliminating the kinds of deaths that are
candidates for cadaveric donations). Thus, the only way to fill the gap in needed
kidneys is to increase the availability of organs from living donors. Without such
an increase in supply, roughly 5,000 people awaiting transplant will die each
year.14 In addition, an uncertain number of other ESRD patients who are not on
the transplant waiting list because they become medically ineligible for a kidney
transplant while waiting will also die.15
The overwhelming majority of living donors have some kind of relationship
with an ESRD patient, most commonly as a parent, sibling, or spouse.16 The motives of such family members are understandable. Furthermore, each year there
are a tiny handful of people who donate a kidney as a matter of pure altruism
without any relationship to a particular donee; however, such donations are rare.
In 2012, there were 5,434 directed kidney donations in the United States, that is,

8. See Adam Gondos et al., Kidney Graft Survival in Europe and the United States: Strikingly Different Long-Term Outcomes, 95 TRANSPLANTATION 267, 269 (2013) (illustrating that survival rates for
kidney grafts decrease over time).
9. See U.S. DEP’T HEALTH & HUMAN SERVS., supra note 4, at 19.
10. Id.
11. See Cook & Krawiec, supra note 3, at 2 (stating that the annual kidney shortage is approximately
21,000 kidneys).
12. See id. at 2–3 (discussing the kinds of deaths that are candidates for organ donation).
13. Id. at 3 (“[E]ven a perfect deceased-organ consent-and-allocation system would have yielded
only about 5500 kidneys in 2011 . . . .”).
14. Id. at 1 (“5,000 people on the waiting list die each year . . . .”).
15. See U.S. DEP’T HEALTH & HUMAN SERVS., supra note 4, at 20 (stating that over 2,000 patients
on the waiting list were removed for being too sick in 2012, but not stating how many of those patients
died while off the waiting list).
16. Cook & Krawiec, supra note 3, at 21 (most donors in 2012 were immediate family members,
frequently spouses, siblings, or parents).
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donations made by a particular donor to a particular donee.17 Most of these donors had some kind of family relationship with the donee. In the same period,
there were a mere 182 undirected donations.18 Overall living donations increased
from 1988 to 2005, but since that time, the number of live donations each year
has been static despite the lengthening waiting list of those with ESRD.19
The availability of a willing donor, however, does not ensure that an ESRD
patient will receive a transplant. Extensive testing is required to ensure that the
donor’s kidney will be acceptable to the donee’s body. A mismatch of blood type
and other genetic characteristics can cause the donee’s body to reject a donated
kidney. It is therefore not uncommon for an ESRD patient to have a donor who
is willing to give a kidney that the patient cannot use.
One possible solution to this problem is a paired kidney donation. In this scenario, there are two patient-donor dyads, AB and CD. A’s kidney is not compatible with B but is compatible with D, while C’s kidney is not compatible with D
but is compatible with A. The dyads agree to swap kidneys. It is possible to conceptualize this transaction as a bargain or sale, but the motives of those involved
are generally altruistic and do not fit easily into our normal models of market
exchange. The recovery rates from a donation nephrectomy are extremely high
and there is no evidence that those who survive face decreased longevity.20 Nevertheless, it is a major surgery that involves substantial discomfort and disruption
of one’s life during recovery and minor but not trivial risks.21 Unsurprisingly, kidney donors are overwhelmingly motivated by an intense concern for a particular
individual rather than a more generalized altruism. Even so, donors sometimes
change their minds at the last minute about donating or may become medically
unable to donate prior to the operation.22 Accordingly, paired donations will ideally occur simultaneously to avoid the risk of a donor losing a kidney without that
donor’s patient receiving one in exchange.
The first bilateral kidney swap in the United States was performed in 2000.23
It soon became clear, however, that longer chains of donations would be needed

17. Id. at 21.
18. Id. at 23.
19. See id. at 9–15 (showing that while the waiting list has increased linearly since 1995 and donations
increased from 1988 to 2005, donations have remained static since 2005).
20. Id. at 7 (“The risk of death within ninety days of surgery is 3.1 per 10,000 donors . . . [and] studies
find no long-term increased risk of mortality among kidney donors.”).
21. See A. J. Ghods, Living Kidney Donation: The Outcomes for Donors, 1 INT. J. ORGAN
TRANSPLANT. MED. 63, 63 (2010) (“the incidence of cardiovascular disease may be higher in kidney
donors”); see also Thomas G. Peters et al., Living Kidney Donation: Recovery and Return to Activities of
Daily Living, 14 CLIN. TRANSPLANT. 433, 435–36 (2000) (describing some side effects and discomfort
reported by forty-two kidney donors).
22. See, e.g., Ingela Fehrman-Ekholm et al., Reasons for Not Accepting Living Kidney Donors, 61
TRANSPLANTATION 1264, 1264–65 (1996) (stating that eighteen potential kidney donors out of 146
changed their minds, nine after undergoing various investigations).
23. See ALVIN E. ROTH, WHO GETS WHAT—AND WHY: THE NEW ECONOMICS OF
MATCHMAKING AND MARKET DESIGN 35 (2016).
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to maximize the number of successful transplants through kidney exchanges.
Sometimes, it will be difficult for a patient–donor dyad to find a dyad with mutually compatible kidneys. In this situation, it may be possible to create extended
chains of donations. Imagine three dyads: AB, CD, and EF. A’s kidney is incompatible with B but is compatible with D. C’s kidney is incompatible with D but is
compatible with F. E’s kidney is compatible with B but not F. In such a situation,
all three patients—B, D, and F—can receive a kidney by linking the donations
together: A donates to D, C donates to F, and E donates to B. We can think of
these as “closed-loop exchanges” because the first donor ultimately gets a kidney
from the final donor for “his” or “her” ESRD patient. To facilitate this process,
kidney exchange clearinghouses were created, first in New England and later in
other regions.24 Donees with incompatible donors register with the exchange,
which then tries to match them with others in the same situation.
What began as a back-of-the-envelope process by transplant surgeons has attracted the attention of economists, mathematicians, and computer scientists,
who have created algorithms for the optimal allocation of kidneys through exchanges. These models suggest that in a pool of representative ESRD patients,
the number of donations should be maximized through exchange loops of three
to four pairs.25 However, in practice the optimal number of connected pairs on
actual exchanges is much, much longer.26 This is because organ exchanges, as they
currently exist, are thin markets. While there is a nascent national exchange program, the availability of organ exchanges still varies dramatically by region. Furthermore, patients with a compatible donor never register with the exchanges,
which means that the pool of patients in the exchanges tends to skew towards
those for whom it is difficult to find a match because of their blood type or antibody response. Hospitals are similarly unlikely to report easy-to-match dyads to
organ exchanges, preferring to arrange those exchanges without the aid of a
clearinghouse.27
In extended kidney exchanges, operations are performed simultaneously.
This ensures that the first-moving donor is not exposed to the risk that someone
down the chain will renege on her promise to donate. Such reneging after the

24. See generally Alvin E. Roth et al., A Kidney Exchange Clearinghouse in New England, 95 AM.
ECON. REV. 376, 376–80 (2005) (recounting the creation of the first exchange clearinghouse in the United
States).
25. See Alvin E. Roth et al., Efficient Kidney Exchange: Coincidence of Wants in Markets with Compatibility-Based Preferences, 97 AM. ECON. REV. 828, 840 (2007) (“While two-way exchanges account for
most of the potential gains from exchange, the number of patients who benefit from exchange significantly increases when three or more pair exchanges are allowed . . . .”); Tayfun Sönmez & Utku M. Unver, Market Design for Kidney Exchange, in THE HANDBOOK OF MARKET DESIGN 93, 116 (Nir Vulkan
et al. eds., 2013) (“[V]irtually all possible gains from trade are achieved with two way, three way, and
four way exchanges, especially when the population size is large[].”).
26. See Itai Ashlagi et al., The Need for (Long) Chains in Kidney Exchange 23 (Nat’l. Bur. Econ.
Res., Working Paper No. 18202, 2012), http://www.nber.org/papers/w18202 [https://perma.cc/7XDV2F9J].
27. Id. at 7.
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initial donation chains would result in irreparable harm, as the first donor’s donee
would not only fail to receive a transplant, but would also lose a kidney with
which she can bargain for a compatible organ in the future. However, it is very
difficult to perform more than about six operations simultaneously.28 Accordingly, nothing more than three or four transplants occurs in closed-loop exchanges, even though if they were to occur, lives would be saved.29
An alternative process known as non-simultaneous extended altruistic donation (NEAD) has recently gained popularity. Unlike in a closed-loop exchange,
the first moving donor in a NEAD chain has no particular patient that she is trying to benefit. The result is that she is never exposed to the risk of irreparable
harm if a downstream donor fails to donate as promised.30 This allows for much
longer chains of donations. NEAD chain have involved as many as thirty-four
transplants.31 While NEAD chains are a very promising development, their use
is limited by the availability of an altruistic donor on the front end of the transaction. Without such a donor, the NEAD chain will not happen.
B. Normative Background
At first glance, the problem of extended kidney exchange looks like an example of what we could think of as the classic contracting problem.32 The basic problem is one of opportunism and the lack of trust that fear of opportunism can create. When, over time, quid is exchanged for pro, there is always the risk that one
party will take the money and run without performing later. As a result, otherwise beneficial transactions do not occur. The traditional solution to this dilemma
is to create legally-enforceable contracts. Once a party enters into a contract, his
ability to defect is sharply limited. This generates sufficient trust for beneficial
transactions to occur.33 The solution to the problem of overly-short closed-loop
exchanges might be to have longer, non-simultaneous exchanges where all the
parties enter into legally enforceable contracts with one another. Despite the apparent elegance of this solution, there are moral, political, legal, and practical

28. ROTH, supra note 23, at 42.
29. See id. at 41–46.
30. Of course, if a downstream donor reneges, the chain is broken and all of the ESRD patients
downstream of the reneging donor are left without a transplant. After having one’s hopes raised, this is
a heart-breaking experience. However, such ESRD patients still have a willing donor with an incompatible kidney, and thus may be able to join a future chain.
31. Byron Pitts et al., Kidney Donor Chain Changes 68 Lives Forever, ABC NEWS (Dec. 11, 2017),
http://abcnews.go.com/Health/donating-kidney-complete-stranger-order-save-loved/story?id=30288400
[https://perma.cc/UJ9U-GKHV]; Kevin Sack, Lives Forever Linked Through Kidney Transplant Chain
124, N.Y. TIMES (Feb. 18, 2012), https://www.nytimes.com/2012/02/19/health/lives-forever-linkedthrough-kidney-transplant-chain-124.html [https://perma.cc/2MUM-ZRB9].
32. See NATHAN B. OMAN, THE DIGNITY OF COMMERCE: MARKETS AND THE MORAL
FOUNDATIONS OF CONTRACT LAW 36 (2016) (discussing the role of contract law is avoiding ex post
opportunism in extended exchanges).
33. See generally OLIVER E. WILLIAMSON, THE ECONOMIC INSTITUTIONS OF CAPITALISM (1985)
(discussing basic contracting problems in great depth).
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reasons for believing the problem cannot be solved so simply.
Most people are deeply uncomfortable with the idea of selling organs. To be
sure, proposals to allow parties to sell kidneys have gained greater acceptance
over the last few decades, but polling suggests that proposals for unregulated organ auctions cannot command widespread social support.34 Numerous scholars
have offered normative arguments against the sale of kidneys.35 First, there is the
argument that allowing the sale of organs by living donors would lead to the exploitation of poor and vulnerable individuals.36 According to this argument, only
the extremely poor and desperate will be willing to sell their kidneys, and it would
be immoral to take advantage of that desperation.
Second, building on the critique of markets offered by Karl Marx and his idea
of commodity fetishism, one could argue that when something is traded within a
market, market participants come to see that thing as being interchangeable with
substitutes in the market and possessed of a purely instrumental value.37 According to this view, the danger in allowing the sale of organs is that it will lead to the
commodification of human bodies and, by extension, the commodification of human beings themselves. Even someone such as Margaret Radin, who argues that
markets need not inevitably lead to full commodification, might worry about the
dangers of partial or incomplete commodification, particularly when dealing with
human bodies.38
Third, there are strong human ideas of the sacred: that which is sacred is defiled when it is traded in a market. The moral intuition is that human bodies are
sacred and therefore should not to be traded. A similar point can be made using
the language of moral pluralism. On this view, the problem with markets is that
they rest on the assumption that all goods can be valued using a single metric.39

34. A 2012 poll of Americans found that 60% supported providing credits for health care costs,
while 41% supported cash payments. Interestingly, 60% of respondents found that there was a difference
between providing compensation for organs and buying organs. Scott Hensley, Poll: Americans Support
Compensation for Organ Donors, NPR (May 16, 2012), http://www.npr.org/sections/healthshots/2012/05/16/152498553/poll-americans-show-support-for-compensation-of-organ-donors
[https://perma.cc/7HER-VWLD].
35. See, e.g., DEBRA SATZ, WHY SOME THINGS SHOULD NOT BE FOR SALE: THE MORAL LIMITS
OF MARKETS 189–205 (2012) (setting forth arguments against markets for kidneys).
36. There is evidence to suggest that this is what is happening internationally in at least some black
market sales of organs. See generally Nancy Scheper-Hughes, The Global Traffic in Human Organs, 41
CURRENT ANTHRO. 191, 224 (2000) (summarizing the evidence for an international black market in
human organs).
37. See KARL MARX & FRIEDRICH ENGELS, THE MARX-ENGELS READER 321 (Robert C. Tucker
ed., 1978) (“There is a physical relation between physical things. But it is different with commodities.
There, the existence of things qua commodities, and the value-relation between the products of labour
which stamps them as commodities, have absolutely no connexion with their physical properties and with
the material relations arising therefrom.”); MARGARET JANE RADIN, CONTESTED COMMODITIES 3
(1996) (“Valuation in terms of dollars implies that all commodities are fungible . . . .”).
38. See RADIN, supra note 37, at 102–14 (discussing incomplete commodification).
39. See ELIZABETH ANDERSON, VALUE IN ETHICS AND ECONOMICS 141–67 (1995) (applying this
theory to the criticism of monistic conceptions of market activity).
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This, so the argument goes, is a philosophical mistake. Some goods are incommensurable with one another. Allowing everything to be traded in the market
fails to recognize this fact and thus values incommensurable goods improperly.
Relatedly, there is the association of the market with self-interest and greed.40
This belief holds that, if sale of organs were allowed, intimate decisions about the
treatment of one’s own body would likewise seep into the market, thus encouraging selfishness in those areas of life that should be protected from the baleful
effects of naked self-interest.
In addition to these (at times abstract) moral concerns, there are also concrete, practical objections against creating an open market for the sale of kidneys.
The presence of a paying market may crowd out altruistic donation and deliver
inferior organs. The seminal text for this argument is Richard Titmuss’s 1971
book, The Gift Relationship: From Human Blood to Social Policy.41 Titmuss compared the process of supplying blood in the United Kingdom and United States.42
At the time, the United States allowed blood banks to pay donors for blood, while
such transactions were illegal in the United Kingdom.43 According to Titmuss,
the United Kingdom outperformed the United States, both in terms of eliminating blood shortages and eliminating contaminated blood.44 Titmuss hypothesized
that the system of payment for blood caused people to become less altruistic, diminishing overall supply.45 In addition, he said that paid donors were drawn
mainly from the “skid row” portion of the population that was disproportionately
affected with hepatitis, which was then the most common medical problem with
blood donations.46
Titmuss’s critique proved powerful in the United States, which abandoned
paid blood donations in the 1970s.47 Some critics of organ sales appeal to Titmuss’s work to support their belief that markets for blood and organs would be
pernicious. In a sensitive reappraisal of Titmuss’s work, however, Kieran Healy
argues that Titmuss’s conclusions are highly contingent on the particular structure of the blood markets of the 1960s and early 1970s.48 The superiority of altruistic donation, Healy argues, is not preordained. He points out that in the early
40. See OMAN, supra note 32, at 42–43 (discussing the association of markets with greed and avarice).
41. See generally RICHARD M. TITMUSS, THE GIFT RELATIONSHIP: FROM HUMAN BLOOD TO
SOCIAL POLICY (1997).
42. See id. at 41–69.
43. See id. at 50, 202 (though some companies in the U.S. regularly pay their donors, the U.K. pays
out, on average, one penny per seven units of blood to donors).
44. See id. at 196–97 (stating that, while 15–30% of American blood supply is lost, the waste in England and Wales was “infinitesimal”).
45. See id. at 239.
46. See id. at 103–10, 113 (illustrating that donors tend to be unemployed, working-class, or uneducated).
47. A system of payments for blood plasma but not whole blood remains.
48. See KIERAN HEALY, LAST BEST GIFTS: ALTRUISM AND THE MARKET FOR HUMAN BLOOD
AND ORGANS 91–92 (2006) (noting that the success of the Titmuss model was due in large part to the
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1980s, the for-profit blood plasma industry was more aggressive in screening donors who might have HIV than were the blood banks who relied on altruistic
donations.49
Healy still credits Titmuss with the insight that both social meaning and institutional context are important for the success of those transfers. He notes the
widespread early suspicion of organ donations and documents the extensive efforts of transplant proponents to craft institutions and social narratives that allayed these fears and that paved the way for widespread donation. The key to
success in this area, Healy argues, has been a narrative surrounding organ donation centered on the ideas of altruism and “the gift of life.”50 He suggests that the
current consensus in favor of organ donation and the value of transplants may be
fragile, which raises the possibility that social support for donation could collapse
if the process is perceived as crassly commercial or exploitive.51
There are plausible objections that can be made to all of these arguments.
Bans on paid transactions that are justified by fears of exploiting the poor may
have the perverse effect of making the poor worse off. In any case, it is by no
means obvious that in a system of paid donations the donors would primarily be
poor. For instance, similar concerns were raised in the early years of surrogate
pregnancies.52 Given the legalization of surrogate pregnancy in several states,
there is now a generation of experience with paid surrogacy markets, and the
women who participate in such markets are not generally poor and desperate.53
Likewise, concerns regarding the commodification of women were frequently
voiced in the early years of egg donations and sales.54 Again, there have been
several decades of experience with these markets, which have not led to a widespread social understanding in which women are valued solely on the basis of
their genetic potential.55 With regard to the desecrating effect of money, one can
look to the experience of life insurance. When it was first introduced in the late–
eighteenth and early–nineteenth centuries, life insurance was widely criticized as
an unholy and devilish effort to benefit from death financially.56 However, people
unusual circumstances of the early 1970s, circumstances which have now changed).
49. See id. at 101–04 (while blood banks were unwilling to screen blood donors for sexual practices
linked to HIV transmission, for-profit companies began screening potential donors for those practices).
50. Id. at 25.
51. Id. at 112 (discussing how the bureaucratic nature of kidney donation grates against the public’s
sensibilities about dead bodies).
52. See RADIN, supra note 37, at 138–39.
53. See Karen Busby & Delaney Vun, Revisiting the Handmaid’s Tale: Feminist Theory Meets Empirical Research on Surrogate Mothers, 26 CAN. J. FAM. L. 13, 22 (2010) (“[T]he empirical data consistently offers little support for the widely expressed concerns about contractual parenting being emotionally damaging or exploitive for surrogate mothers, children, or intended/social parents.”). For a more
skeptical collection of anecdotes, see Martha A. Field, Compensated Surrogacy, 89 WASH. L. REV. 1155,
1170–71 (2014).
54. See RADIN, supra note 37, at 138–39 (positing reasons for society’s aversion to the sale of babies).
55. See OMAN, supra note 32, at 170 (discussing the experience with egg donation markets).
56. See ROY KREITNER, CALCULATING PROMISES: THE EMERGENCE OF MODERN AMERICAN
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were able to craft understandings of life insurance, such as the altruistic desire to
care for one’s dependents after death, which robbed the product of its blasphemous character. This article does not seek to rehash or contribute to these debates. It is enough to note that the idea of selling kidneys is controversial, and for
that reason, it is unlikely that widespread political support for a robust-but-regulated market in kidneys is currently possible.57
C. Legal Background
There are also major legal impediments to the creation of enforceable contracts around extended kidney exchanges. In 1984, Congress reacted to growing
unease around new technologies involving transplants and reports that some people were trying to sell their kidneys.58 The result was the National Organ Transplant Act (NOTA).59 The law created a national system for the distribution of
organs that ultimately came to be administered by the United Network for Organ
Sharing (UNOS), a nonprofit corporation that administers the program under a
contract with the United States government.60 The act also declared, “it shall be
unlawful for any person to knowingly acquire, receive, or otherwise transfer any
human organ for valuable consideration for use in human transplantation if the
transfer affects interstate commerce.”61 Violation of the law is a crime that can
result in a fine of up to $50,000 and five years in prison.62
In 2007, NOTA was amended by the Charlie W. Norwood Living Organ Donation Act (Norwood Act), which states that the prohibition on the transfer of
human organs for “valuable consideration . . . does not apply with respect to human organ paired donation.”63 On its face, the statutory definition of “human
organ paired donation” seems to include extended kidney exchanges.64 However,
such extended kidney exchanges are nevertheless excluded if the participants in
the transaction receive anything other than a human organ in exchange for their
CONTRACT DOCTRINE 126–46 (2007) (recounting the early history of life insurance).
57. See generally T. Randolph Beard & Jim Leitzel, Designing a Compensated-Kidney Donation
System, 77 LAW & CONTEMP. PROBS., no. 3, 2014, at 253 (discussing what a regulated system of compensated kidney donation might actually look like in the United States).
58. 129 CONG. REC. 25232 (daily ed. Sept. 21, 1983) (statement of Rep. Gore) (arguing that kidney
transplantation technology dehumanizes people).
59. National Organ Transplant Act, Pub. L. No. 98-507, 98 Stat. 2339 (1984) (codified as amended
at 42 U.S.C. §§ 273, 274-274e (2012)).
60. See History of UNOS, UNOS, https://www.unos.org/about/history-of-unos/ [https://perma.cc/
AG57-JTQE] (last visited Sept. 5, 2017).
61. 42 U.S.C. § 274e(a) (2012).
62. 42 U.S.C. § 274e(b) (2012) (“Any person who violates subsection (a) of this section shall be fined
not more than $50,000 or imprisoned not more than five years, or both.”).
63. Charlie W. Norwood Living Organ Donation Act, Pub. L. No. 110-114, 121 Stat. 1813 (2007)
(codified at 42 U.S.C. §§ 273b, 274e (2006 & Supp. IV 2011)). The Department of Justice’s Office of
Legal Counsel subsequently concluded that kidney exchanges did not violate the original unamended
version of NOTA. See Legality of Alternative Organ Donation Practices under 42 U.S.C. § 274e, 31 Op.
O.L.C. 40 (2007).
64. See 42 U.S.C. § 474e(c)(4)(D)–(E).
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donation. Thus, a paired donation in which a person received not simply a kidney
for a loved one, but also a cash payment, would be subject to the criminal prohibition on receiving “valuable consideration” in the transfer of “any human organ.” In short, under current law, kidneys may only be traded for kidneys.
Federal law merely states that transactions in which kidneys are exchanged
for one another is not a federal crime. It does not follow from this that agreements to exchange kidneys are legally enforceable contracts.65 First, there is the
question of whether such a contract would satisfy the requirements of offer, acceptance, and consideration. The answer is most likely yes.66 However, it is worth
noting that whether these transactions involve consideration might be arguable.
The requirements of contractual consideration are a famously obscure question, one with which law professors have been tormenting first-year law students
for over a century. Generally, the modern position is that in order for a promise
to have consideration, there must be a bargain in fact between the parties.67 In
the case of extended kidney exchanges, the bargain in fact would be the promised
exchange of kidneys. However, one might argue that the promise to donate a
kidney in this case is gratuitous, albeit subject to the condition that the patient in
the donor-patient dyad receives a kidney. In other words, the midstream donor
is not actually engaged in a quid pro quo, but rather makes a conditional gift. The
distinction is that between a gratuitous promise containing a condition, which remains a nudum pactum notwithstanding the condition, and a true bargain. Admittedly, the distinction is obscure, and the extended kidney exchange can be
easily characterized as a complex bargain. However, common law courts have
often manipulated the doctrine of consideration to allow or deny enforcement of
agreements based on the judges’ sub rosa substantive evaluation of the underlying transaction.68 Given the widespread discomfort with the transfer of organs in
anything that looks like a sale, there is always the possibility that a judge would
refuse to enforce a kidney exchange contract based on a consideration argument.
Perhaps more plausibly, there is also the possibility that, when faced with a
suit to enforce a contract for the exchange of kidneys, a court would refuse to do
so on public policy grounds. There are no reported American cases addressing
the issue. Numerous states have criminal prohibitions on the sale of organs for

65. Indeed, one might argue that receiving a legally enforceable promise of a kidney, rather than a
kidney itself, might be “valuable consideration” of the kind prohibited by NOTA. 42 U.S.C. § 474(a)
(2012).
66. See Kieran Healy & Kimberly D. Krawiec, Custom, Contract, and Kidney Exchange, 62 DUKE
L.J. 645, 665–66 (2012) (arguing that promises between kidney donors could result in a legally enforceable contract).
67. See RESTATEMENT (SECOND) OF CONTRACTS § 71 (AM. LAW INST. 1981) (“Requirement of
Exchange”).
68. See, e.g., GRANT GILMORE, THE DEATH OF CONTRACT 68–69 (1995) (discussing Justice
Cardozo’s manipulation of the doctrine of consideration during his tenure on the New York Court of
Appeals).
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valuable consideration.69 Contracts to commit an illegal act are, of course, unenforceable.70 However, some states have specific statutory exemptions stating that
organ exchanges in paired donations are not illegal.71 Setting these statutes aside,
courts have frequently refused to enforce contracts on public policy grounds
when the subject matter of the contract touches on intimate matters or involves
personal decisions about the use of one’s body. Examples of the former category
include the refusal to enforce a contract that would result in a man becoming a
father via the implantation of a frozen embryo without his ongoing consent.72 Examples of contracts in the latter category include the refusal of courts to enforce
surrogacy contracts in which a woman promises to carry a child to term on behalf
of another couple.73 Even where such agreements are not prohibited by law,
courts may refuse to lend the assistance of the state in enforcing them. Again,
given the widespread discomfort with anything resembling coerced organ donation, it is certainly possible that courts would refuse to enforce contracts to donate
because of the breaching party’s immediate refusal to undergo surgery.
Finally, there is the question of what legal enforcement of a contract would
even mean in this context. It is inconceivable that a court would order specific
performance where someone who promised to give up a kidney subsequently refuses to undergo an operation. Courts have long refused to specifically enforce
ordinary personal services contracts—contracts that often involve nothing more
controversial than the performance of ordinary professional services in return for
lucrative compensation.74 To imagine an American court requiring someone to
submit to an invasive surgical procedure on pain of contempt is fanciful.

69. See, e.g., ALA. CODE § 22-19-175 (1975); ARIZ. REV. STAT. ANN. § 36-854 (2007); ARK. CODE
ANN. § 20-17-802 (2017); CAL. PENAL CODE § 367f (West 2011); COLO. REV. STAT. ANN. § 12-34-116
(West 2017); DEL. CODE ANN. tit. 11, § 1333 (West 1995); D.C. CODE ANN. § 7-1501.01 (West 2008);
FLA. STAT. ANN. § 873.01 (West 1999); GA. CODE ANN. § 16-12-160 (West 2008); HAW. REV. STAT.
ANN. § 327-16 (West 2008); IDAHO CODE ANN. § 39-3417 (West 2007); 720 ILL. COMP. STAT. ANN. 5/1220 (West 2011); IND. CODE ANN. § 35-46-5-1 (West 2016); IOWA CODE § 142C.10 (West 2007); KAN.
STAT. ANN. § 65-3235 (West 2007); LA. STAT. ANN. § 14:101.1 (1986); MICH. COMP. LAWS ANN. §
333.10116 (West 2008); MINN. STAT. ANN. § 145.422 (West 1973); MO. ANN. STAT. § 194.275 (West 2008);
MONT. CODE ANN. § 72-17-302 (West 1989); NEV. REV. STAT. ANN. § 201.460 (West 1987); N.H. REV.
STAT. ANN. § 291-A:11 (2010); N.J. STAT. ANN. § 2C:22-2 (West 2008); N.M. STAT. ANN. § 24-6B-16
(West 2007); N.Y. PUB. HEALTH LAW § 4307 (McKinney 2009); OR. REV. STAT. ANN. § 97.981 (West
2008); 35 PA. STAT AND CONS. STAT. ANN. § 10025 (West 1984); S.C. CODE ANN. § 44-43-10 (2009);
TEX. PENAL CODE ANN. § 48.02 (West 2017); VT. STAT. ANN. tit. 9A, § 2-108 (West 1989).
70. See RESTATEMENT (SECOND) OF CONTRACTS § 179 (AM. LAW INST. 1981) (“Bases of Public
Policy Against Enforcement”).
71. See, e.g., CAL. HEALTH & SAFETY CODE § 7152.2(a) (West 2011); N.Y. PUB. HEALTH LAW
§4307(b) (2009).
72. See A.Z. v. B.Z., 725 N.E.2d 1051, 1059 (Mass. 2000) (refusing to enforce the provisions of a
contract with a fertility center).
73. See In re Baby M, 537 A.2d 1227, 1264 (N.J. 1988) (refusing to enforce the provisions of a surrogacy agreement relating to custody).
74. See generally Nathan B. Oman, Specific Performance and the Thirteenth Amendment, 93 MINN.
L. REV. 2020 (2009) (discussing the relationship between specific performance of personal service contracts and the Thirteenth Amendment).
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One could, of course, enforce the contract through the award of damages.
Here, two problems arise. First, there would be the difficulty of calculating damages. Current contract doctrine requires that damages be fixed with certainty.75
The most common way in which this occurs is by awarding the disappointed
breachee the difference between the contract price of what was promised and the
market price at the time of breach.76 Given the absence of a non-black market
price for kidneys, it would be very difficult to determine this figure.77 Likewise,
consequential damages must be foreseeable at the time the parties enter into the
contract.78 However, there is necessarily a great deal of uncertainty as to the ultimate outcome of any transplant operation.79 Therefore, it would be difficult to
determine, for example, whether the transplant would have been successful had
it been made and how long the kidney would have continued to function after the
transplant. Again, unless these figures can be fixed with certainty damages will
not be awarded. The second problem is not legal, but practical. Presumably, the
consequences of giving up a kidney and receiving nothing in return, or of being
denied a life-saving transplant that was promised, would be severe. Suppose the
courts were comfortable placing a large dollar figure on this damage. Most individuals are likely to be judgment proof; many will not have the assets to satisfy
such an award, and many of those who have assets that might be attached will
nevertheless be protected by state homestead exemptions and other debtor protections. In short, an ordinary suit for damages, even if available as a matter of
law, is a largely empty threat.
III
PROPOSAL ONE: STANDBY LETTERS OF CREDIT AND CLOSED-LOOP KIDNEY
EXCHANGES
Given that the optimal allocation of kidneys in current exchanges requires
donation chains that are longer than three transplants, non-simultaneous, closedloop kidney exchanges should be considered. There are two problems with such
non-simultaneous exchanges. The first is the risk that someone would give a kidney on behalf of a loved one to a stranger but that his loved one will ultimately
75. See RESTATEMENT (SECOND) OF CONTRACTS § 352 (AM. LAW INST. 1981) (“Uncertainty as a
Limitation on Damages”).
76. See U.C.C. § 2-713(1) (AM. LAW INST. & UNIF. LAW COMM’N 2002) (“the measure of damages
for non-delivery or repudiation by the seller is the difference between the market price at the time when
the buyer learned of the breach and the contract price”).
77. See Scheper-Hughes, supra note 36 (discussing the black-market trade in human organs).
78. See Hadley v. Baxendale, 156 Eng. Rep. 145 (Ex. Ch. 1854) (holding that consequential damages
must be foreseeable at the time of formation in order to be recoverable).
79. See Kidney Disease Statistics for the United States, NAT’L INST. DIABETES & DIGESTIVE &
KIDNEY
DISEASES,
https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease
[https://perma.cc/5SMJ-VQ7H] (last visited Nov. 6, 2017) (“The probability of patient survival within 1
year post-transplant was 95% and 98% in deceased and living donor kidney transplant recipients, respectively, in 2012.”).
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not receive a kidney in return because someone down the chain of donations reneges on their commitment to donate. Very little can be done to guard against
this risk—once a person decides to renege on their promise to donate, that person
will not be forced to make the donation. The second problem is related to the
first. When it is difficult to determine whether the person further down the line
is going to perform, initial donors will not participate in a closed-loop exchange
without an assurance of performance. The risk here is not that donors will enter
into an agreement and then the agreement will go bad. Rather, the risk is that
they will never enter into the agreement in the first place.
Because currently, closed-loop extended kidney exchanges are performed
simultaneously, there is very limited information on how common reneging
would be were we to attempt non-simultaneous exchanges.80 However, there are
documented cases of such reneging occurring when exchanges happen over a
long period of time.81 A study of NEAD operations conducted between 2008 and
2016 found that slightly more than 5% of chains were broken, most often because
a transplant or donation was no longer medically possible.82 However, there were
still a tiny handful of cases where donors simply backed out before donating.83
The evidence that we have suggests that reneging is likely to be very rare, but
without a way of limiting this risk, non-simultaneous, closed-loop exchanges are
unlikely to be performed.84
The purchase of a performance bond could mitigate against both problems.
One advantage of the bond mechanism is that it can use well-established commercial devices that are largely self-enforcing. It can also be presented as relying
not on the suspect mercenary logic of an impersonal market that so concerns critics of organ sales, but rather on the moral logic of honor, fidelity to one’s word,
and the protection of the vulnerable. Bonds are a common commercial device
and can take a variety of forms.85 One typical example is a performance bond in

80. See Kieran Healy & Kimberly D. Krawiec, Organ Entrepreneurs, in CAMBRIDGE HANDBOOK
(D. Gordon Smith & Christine Hurt eds., forthcoming 2018) (manuscript at 11), https://kieranhealy.org/files/papers/orgentrep.pdf [https://perma.cc/B58N-NAJ8] (“It
should be noted that NEAD chain donor reneging is extremely rare, but not unheard of.”).
81. See, e.g., S. E. Gentry et al., The Roles of Dominos and Nonsimultaneous Chains in Kidney
Paired Donation, 9 AM. J. TRANSPLANT. 1330, 1335 (2009) (“Donor reneging broke a NEAD chain at
Johns Hopkins. In this instance there was a long interval between the intended recipient’s transplant
from an NDD and the request for the bridge donor to participate in the next transplant.”); see also Healy
& Krawiec, supra note 80, manuscript at 11 (“It should be noted that NEAD chain donor reneging is
extremely rare, but not unheard of.”).
82. See N. Cowan et al., Broken Chains and Reneging: A Review of 1748 Kidney Paired Donation
Transplants, 17 AM. J. TRANSPLANT. 2451, 2452 (2017) (reporting a study of 1,748 kidney donations in
loop or chain transactions).
83. See id. at 2454 (finding six cases where donors reneged).
84. See S. E. Gentry et al., supra note 81, at 1330 (“We are not aware of any other chains that have
been broken by an unwilling or ineligible bridge donor. However, only short-term implementation data
are available, and long waits between the time one’s intended recipient gets a kidney and the time one is
asked to donate seem certain to increase the risk of reneging.”).
85. See generally THE LAW OF COMMERCIAL SURETY AND MISCELLANEOUS BONDS (Bruce C.
ON LAW AND ENTREPRENEURSHIP
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a construction contract, where a general contractor purchases a guarantee from
a bank, which ensures that the bank will either pay subcontractors in the event
that the general contractor fails to do so or will pay the property owner in the
event that the general contractor fails to construct the building as promised. In
this case, the bond provides a kind of insurance against nonperformance of the
commercial obligation. However, as a matter of law, there is no reason that a
bond must guarantee such a commercial obligation. As it currently stands, commercial law provides a device that could be used in non-simultaneous, closedloop exchanges: the standby letter of credit.
A. Letters of Credit
The letter of credit is a commercial device that was developed as part of the
lex mercatoria, a transnational body of law created by European merchants in the
Middle Ages.86 It was originally used mainly in international transactions for the
sale of goods. Suppose a weaver in Antwerp wished to buy wool from an English
merchant. The weaver would approach a bank with a branch in England. For a
fee, the bank would agree to issue a letter of credit to the English merchant. The
letter would state that upon presentation of documents certifying shipment of the
wool to the weaver, the bank would pay the merchant the purchase price of the
wool. Upon receipt of the letter, the merchant would ship the wool to Antwerp
and present the bank with receipts issued by the carrier. Upon finding that the
receipts complied precisely with the documents demanded by the letter of credit,
the bank would pay the merchant. The bank could then demand reimbursement
from the weaver, who might have pre-funded the draw. In this example, the letter
of credit performs two functions. First, it substitutes the credit of the bank for the
credit of the weaver. Second, it eliminates the risk of a legal dispute over payment
on the sale. The bank’s only concern in paying out under the letter of credit is
whether the merchant presented documents conforming to those contained in the
letter of credit. The bank was not required to inquire into the underlying facts or
substance of the sale of the wool.
Some version or another of this classic letter of credit transaction remains
common in international trade.87 However, a new device called the standby letter
of credit has become common, particularly after the adoption of Article 5 of the
Uniform Commercial Code governing letters of credit in the 1960s.88 Whereas

King et al. eds., 2d ed. 2012) (summarizing the various kinds of commercial bonds and the legal issues
that they create).
86. See generally JOHN F. DOLAN, THE LAW OF LETTERS OF CREDIT: COMMERCIAL AND
STANDBY CREDITS § 3.02 (4th ed. 2007) (discussing the early history of letters of credit); JAMES STEVEN
ROGERS, THE EARLY HISTORY OF THE LAW OF BILLS AND NOTES: A STUDY OF THE ORIGINS OF
ANGLO-AMERICAN COMMERCIAL LAW (2004) (discussing the early history of bills of exchange and
letters of credit).
87. See DOLAN, supra note 86, § 1.01 (discussing the role of letters of credit in contemporary commercial practice).
88. See id. § 1.05 (discussing the rise of standby letters of credit).
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the primary purpose of the traditional letter of credit is to secure payment of a
debt, the primary purpose of the standby letter of credit is to secure the performance of an obligation. A standby letter of credit can thus perform a function
similar to a traditional surety agreement, such as a performance bond. But a
standby letter of credit differs legally from a surety contract in ways that make it
an ideal device for increasing trust in non-simultaneous kidney exchanges.
To understand how a standby letter of credit works, consider an example. A
general contractor promises to build a house for an owner according to the specifications of an architect. In order to put to rest the owner’s concerns about the
house being built properly, the contractor pays a bank to issue a letter of credit
to the owner, under which the bank will pay the owner a substantial sum of
money if the owner presents the bank with documents from an architect stating
that the house has not been completed according to specifications. Unlike in the
traditional letter of credit transaction—where if all goes well, the beneficiary of
the letter (the merchant) will present conforming documents to the bank and be
paid—in a standby letter of credit transaction, if all goes well, the beneficiary (the
owner) will never offer the documents required under the letter of credit. The
point of the standby letter of credit is to ensure that the house is built, not to pay
the owner.
This is a situation where the general contractor could also enter into an ordinary surety contract with the bank. However, the surety contract has different
legal characteristics than the standby letter of credit. In a surety agreement, the
bank would guarantee the contractor’s performance of the contract with the
owner. While a bank with a surety cannot raise so-called “personal defenses”89—
most notably the unenforceability of a contract because of the running of the
statute of limitations,90 or discharge of an obligation in bankruptcy91—he can raise
other defenses with a surety, such as material breach,92 lack of consideration on
the underlying contract with the owner,93 or public policy objections to that contract.94 In contrast, under a standby letter of credit, the bank cannot raise any of
these defenses;95 once conforming documents are presented, the bank must pay.
The principle of independence is central to letter of credit law. A letter of
credit is generally coupled with some underlying transaction, as when it is used
to pay for the purchase of goods or to guarantee performance of some obligation

89. See SAMUEL WILLISTON & RICHARD A. LORD, TREATISE ON THE LAW OF CONTRACTS § 61:7
(4th ed. 1990) (stating that personal defenses are unavailable to a surety).
90. See id. (“the surety may not plead the running of the statute of limitations”).
91. See id. § 61:8 (“one liable with the bankrupt as a surety on a debt is not relieved of liability by
the discharge of the principal obligor in bankruptcy.”).
92. See id. § 61:7 (“[T]he surety may plead the defenses that are available to the principal.”); id. §
43:5 (stating that one party’s material breach discharges the other party’s duties under the contract).
93. See id. § 7:8, § 61:7 (stating that, in general, legally enforceable promises require consideration).
94. Id. § 12:1, § 61:7 (stating that contracts in violation of public policy are unenforceable).
95. Id. § 2:23 (“[T]he letter of credit obligates the issuer to pay drafts or other demands . . . independent of any underlying contract between the customer and the beneficiary.”).
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as with a standby letter of credit. The independence principle means that the obligation on a letter of credit is independent of the underlying transaction in which
the letter of credit is being used.96 For example, suppose that a letter of credit is
used to pay for goods. The goods are shipped, and shipping receipts conforming
to the letter are presented to the issuing bank. The bank must pay under the letter
of credit. This is true even if the shipped goods are non-conforming and thus,
under the U.C.C.’s perfect tender rule, payment is not actually due.97 Of course,
one can always litigate about the non-conforming goods later, but commercial
law has developed so that under the letter of credit, as much payment as possible
is insulated from any legal risk associated with the underlying transaction.98
The independence principle applies even when the underlying transaction is
infected with fraud or some other legal defect. Perhaps the starkest statement of
the independence principle comes in section 5-109 of the U.C.C., which deals with
an issuer who is presented with forged—but otherwise conforming—documents.
In such a case, “the issuer shall honor the presentation” if it is made by a third
party to the fraud, and may honor the presentation even if it is made by the person who forged the documents, so long as the issuer is “acting in good faith.”99
Independence extends even beyond the truth of the documents presented under
the letter. For example, an issuer cannot raise the illegality of the underlying
transaction as a defense when it refuses to pay in the face of a presentation of
conforming documents.100
B. Letters of Credit and Extended Kidney Exchanges
In an extended kidney exchange, each patient-donor dyad could purchase a
letter of credit from a financial institution, such as a bank. The letter would then
be given to the initial participant in the proposed non-simultaneous exchange
transaction. Under the terms of the agreement with the bank, the bank would
96. For example, the Uniform Commercial Code provides:
An issuer is not responsible for:
(1) the performance or nonperformance of the underlying contract, arrangement, or transaction,
(2) an act or omission of others, or
(3) observance or knowledge of the usage of a particular trade. . .
U.C.C. § 5-108(f) (AM. LAW INST. & UNIF. LAW COMM’N 1995).
97. See WILLISTON AND LORD, supra note 89, § 2:23 (“the letter of credit obligates the issuer to pay
drafts or other demands . . . independent of any underlying contract between the customer and the beneficiary”).
98. See id. § 2:23. See also Benetton S.p.A. v. Benedot, Inc., 642 So.2d 394, 396, 400–01 (Ala. 1994)
(illustrating that a plaintiff can litigate over nonconforming goods after settling disputes related to a letter
of credit).
99. See U.C.C. § 5-109(a)(1)–(2) (AM. LAW INST. & UNIF. LAW COMM’N 1995).
100. See, e.g., Ross Bicycles, Inc. v. Citibank, N.A., 577 N.Y.S.2d 826, 828 (N.Y. App. Div. 1991)
(“The real issue is the question of the illegal activities of Wedtech and possible illegal aspects of the
plaintiff’s dealing with Wedtech. . . . The suit is not on the underlying contract but on the letter of
credit. . . . [T]he defendant is a ‘third party’ . . . which cannot use this defense.” (internal citations omitted)).
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pay on the letter if proof of three conditions were satisfied. First, the patientdonor dyad that purchased the letter of credit must have received a kidney as
part of the non-simultaneous exchange. Second, the donor in the purchasing patient-donor dyad must have failed to donate a kidney as provided in the original
extended kidney exchange agreement. Third, the presenting party must be a donor in a patient-donor dyad who donated a kidney under the extended kidney
exchange agreement but whose patient did not received a kidney in return.101
In the context of non-simultaneous exchange, the standby letter of credit has
the virtue of eliminating legal risk about the enforceability of any underlying contract. As discussed above, a promise to donate a kidney as part of an extended
kidney exchange might be a valid contract, but there is certainly reason to doubt
this. Letter of credit law however, eliminates the need to resolve this question.
The standby letter of credit also eliminates enforcement risk. In the event of a
broken promise to donate a kidney, the disappointed party does not have to bring
suit. He must merely present conforming documents to the issuer of the letter of
credit, who will then pay automatically. Finally, by substituting the credit worthiness of the bank for the creditworthiness of the donor, the letter of credit eliminates the risk of a judgment-proof donor. In short, the entire transaction becomes
self-enforcing, which was, of course, the historical reason that letters of credit
were developed in the first place.
What would be the effect of this standby letter of credit? First, the standby
letter of credit provides a credible signal of trustworthiness. Talk is cheap, but
reneging on a promise that is backed by a standby letter of credit would be very
expensive. Indeed, even if a donor performs his promise and therefore does not
have to indemnify the bank, entering into the transaction in the first place would
be expensive. Even the performing donor would have to incur both the cost of
compensating the bank for issuing the letter and the time value of the money
during the period when it was in escrow. This expense would serve a precautionary function: it would weed out those who are not serious about donating.102 It
would also weed out any opportunistic individuals who would make a false promise in order to induce donation from another, although the very limited evidence
suggests that akrasia, rather than predation, is the problem.103 The standby letter
of credit thus functions like a used car warranty, which not only shifts the risk of
breakdowns from buyer to seller, but also overcomes information asymmetries
by signaling quality.104
101. Technically, such a letter would allow a downstream donor to renege, provided that the reneging
party arranged the initial donor’s ESRD patient to receive a kidney. Thus, the letter would not secure a
donor’s actual performance, but would only secure the supply of a kidney, which is all that is necessary
to generate the trust demanded for a non-simultaneous exchange.
102. Cf. Lon L. Fuller, Consideration and Form, 41 COLUM. L. REV. 799, 800–06 (1941) (discussing
the role of formalities in contract law).
103. See supra notes 80–83 (showing that reneging is very rare and not finding a single case involving
predatory reneging, i.e., a deliberate choice to take a kidney and run rather than living up to a bargain).
104. See generally George Akerlof, The Market for “Lemons”: Quality Uncertainty and the Market
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Second, it would reduce—but certainly not eliminate—the amount of risk undertaken by the first moving donor in a non-simultaneous exchange. This is the
donor who is exposed to the risk that she will give up a kidney on behalf of a
loved one without receiving a kidney for that loved one in exchange. Under the
standby letter of credit, in this situation the donor would be paid a large sum of
money. From this donor’s point of view, payment on the letter of credit can be
thought of in a number of ways. It could be seen as a straightforward purchase of
a kidney for money. However, the original term of the deal between the donors
in the exchange was never to sell a kidney for money. Indeed, the donors do not
desire to receive money, but rather a kidney for their loved one, and there is no
reason to suppose that they would accept an offer to purchase their kidney for
cash were such an offer legal.
A better way to think about the payment, from the disappointed donor’s point
of view, is that it constitutes a kind of insurance. The point of a life insurance
policy is not to make a payment that renders the beneficiary indifferent between
money and the life of a loved one.105 Rather, a life insurance policy reduces the
risk to which one is exposed in the event of the policyholder’s death, even though
it does not fully eliminate that risk. Likewise, the possibility of a payout under
the standby letter of credit in the event that that a donor gives up her kidney
without receiving a kidney in return for her loved one mitigates a substantial risk.
The possibility of a cash payment does not eliminate such a risk, but it would
make it marginally more tolerable. Payment does not change the fact that the
initial donor is entering into the exchange not in the hope of cash, but in the hope
of a kidney for a loved one. By making the risk marginally more tolerable, the
initial donation is more likely to occur, with benefits for all of the patients involved.
Third, the letter of credit provides a financial incentive for its purchaser to
carry through on his promise to donate a kidney. A surety is obligated to pay a
bond regardless of whether the purchaser of that bond is willing or able to indemnify the guarantor for that payment. That is, of course, the point of the surety.
Likewise, the complete independence of the various parties’ obligations to a letter of credit is precisely what makes that instrument different than an ordinary
contract, which could be subject to implied conditions, such as the doctrine of
material breach. That said, banks are unwilling to issue a standby letter of credit
unless the purchaser of the letter is willing to deposit money with the bank, to
indemnify the bank in the event that it is later obligated to pay under the letter.
In the context of a non-simultaneous exchange, this would mean that each donor
would be required to place a very large sum of money in the bank as part of the

Mechanism, 84 Q. J. ECON. 488 (1970) (providing the canonical treatment of information asymmetries in
economics).
105. Such indifference is, of course, the economic precondition for a sale. If the payment of money
does not render a seller at least indifferent as between the money and the objects sold, no exchange will
occur.
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exchange. Should the donor renege on her commitment to donate a kidney, this
money would be lost. However, if she donates as promised, the money will be
returned. In that case, the donor’s financial cost would be limited to the fee that
was paid to the bank for the issuance of the letter and the time value of the money
during the period when it was in escrow. In short, the standby letter of credit
creates a financial hostage that incentivizes the donor’s performance. This mechanism would be largely self-enforcing, thus eliminating the cost and risk of postbreach litigation. Banks never renege on letters of credit unless they are insolvent, and set off rights allow them to obtain deposited money without suit.
The fourth benefit is not financial, but is rather moral and psychological. The
letter can be understood as a pledge of fidelity by the donor on his promise to
give up a kidney. This is not a sale. To the extent that there is a bargain, it ultimately involves the exchange of a kidney for a kidney, a transaction that our society has already judged to be acceptable.106 The problem with non-simultaneous
exchange is that it involves not simply giving up a kidney on behalf of a loved
one, but a promise to give up a kidney on behalf of the loved one. The promise,
like the completed gift, is an act of altruism. The donor suffers a major cost in the
form of a lost kidney for the sole purpose of allowing a loved one to live by procuring a kidney for that loved one. Indeed, it is only the genetic accident of mismatched tissue that prevents the donor from giving his kidney directly to his loved
one. The fact that the exchange occurs over time, rather than simultaneously, in
no way undermines the transaction’s basically altruistic structure.
However, once we inject the practice of promising into this particular act, another set of moral obligations comes into play; namely, the demands of honoring
one’s word. To be sure, fidelity to commitments is an important part of commercial exchange and the ordinary marketplace.107 However, fidelity to one’s word is
not an inherently commercial virtue. Think of the moral obligation of the spouse
to honor his wedding vows or the public official who takes an oath to faithfully
execute the laws of the United States.108 Everyone understands these to be solemn obligations; obligations whose breach would justifiably expose the breacher
to the community’s scorn. The person who promises to donate a kidney has also
made a sort of oath. Just as organ procurement organizations have, over the last
generation, cultivated an ethic of altruistic generosity around organ donation, an
emphasis on honor and fidelity to one’s word can be used to create a similarly

106. See 42 U.S.C. § 274e(a) (2012) (exempting organ swaps from the prohibition on selling organs).
107. See OMAN, supra note 32, at 76–85 (discussing the relationship between market exchange and
the morality of fidelity); DAVID C. ROSE, THE MORAL FOUNDATION OF ECONOMIC BEHAVIOR (2011)
(arguing that without internal moral checks on opportunistic behavior widespread market exchange is
not possible).
108. See U.S. CONST. art. II, § 1, cl. 8 (“Before he enters the Execution of his Office, he shall take the
following Oath or Affirmation:—‘I do solemnly swear (or affirm) that I will faithfully execute the Office
of President of the United States, and will to the best of my Ability, preserve, protect and defend the
Constitution of the United States.’”).
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positive ethic around non-simultaneous exchange.109 On this view, the value of
the standby letter of credit is that the heightened formality of its execution emphasizes to the donor the solemnity of the promise that she is making and invites
her to place her character on the line by “putting her money where her mouth
is.”
C. Standby Letters of Credit, Governing Kidney Donations, and Current Law
The risk remains that a standby letter of credit in non-simultaneous exchange
would violate NOTA. There are two ways of dealing with this problem. It is possible that under the law as it is currently written, a standby letter of credit does
not violate federal law. The second approach would be to change existing federal
law. Turning first to the question under current law, while 42 U.S.C. § 274e
makes it a crime to “transfer any human organ for valuable consideration for use
in human transplantation,”110 the law goes on to state: “The term ‘valuable consideration’ does not include reasonable payments associated with the removal,
transportation, implantation, processing, preservation, quality, control, and storage of a human organ . . . .”111 One might argue that the money paid under a
standby letter of credit comes under this language. The Department of Justice’s
Office of Legal Counsel, for example, determined that the term “valuable consideration” included only for-profit exchanges of cash for organs.112 A second
route under current law, comes under the Norwood Act. The Act exempts “human organ paired donation” from the prohibition on the transfer of an organ for
“valuable consideration.”113 The Act explicitly recognizes extended exchanges by
blessing agreements between more than two patient-donor dyads.114 Furthermore, the Act blesses “a single agreement [among donors and patients] to donate
and receive such human organs, respectively, according to such biological compatibility in the group.”115 One could argue that such an agreement is thus not a
crime, even if it involves a legally-enforceable contract. Finally, the Act insists
that “other than” an agreement among multiple patient and donors, no other valuable consideration can be received as part of a paired organ exchange.116 One

109. See Healy & Krawiec, supra note 66, at 659 (quoting F.K. Butt et al., Asynchronous, Out-ofSequence, Transcontinental Chain Kidney Transplantation: A Novel Concept, 9 AM. J. TRANSPLANT.
2180, 2183 (2009)) (stating that good will, honesty, and generosity ground donors’ faith in NEAD chains).
110. 42 U.S.C. § 274e(a) (2012).
111. 42 U.S.C. § 274e(c)(2) (2012).
112. See Legality of Alternative Organ Donation Practices Under 42 U.S.C. § 274e to Gen. Counsel
Dep’t of Health and Human Servs., 31 Op. O.L.C. 40 (2007).
113. 42 U.S.C. § 274e(a) (2012).
114. See 42 U.S.C. § 274e(c)(4)(D) (2012) (“If there is any additional donor-patient pair as described
in subparagraph (A) or (B), each donor in the group of donor-patient is biologically compatible as a
donor of a human organ for a patient in such group.”).
115. 42 U.S.C. § 274e(c)(4)(E) (2012).
116. See 42 U.S.C. § 274e(c)(4)(F) (2012) (“Other than as described in subparagraph (E), no valuable
consideration is knowingly acquired, received, or otherwise transferred with respect to the human organ
referred to in such subparagraph.”).

OMAN_FINAL_6-5-18 (DO NOT DELETE)

No. 3 2018]

6/5/2018 3:31 PM

BEYOND GIFT AND BARGAIN

59

could argue that because the stand by letter of credit does nothing but secure an
agreement among multiple patients, it comes within the “other than” exclusion.
Both of these statutory arguments are, however, extremely doubtful. No reported cases interpret this language and it is unlikely that either argument would
be successful. A broad reading of the “removal, transportation, implantation,
processing, preservation, quality, control, and storage” language in § 274e(c)(2)
could effectively make an exception swallow the statute’s basic prohibition on
transferring human organs for “valuable consideration.”117 Moreover, the Norwood Act argument runs into the very independence principle that makes the
standby letter of credit otherwise attractive. The right to payment under such a
standby letter of credit would be, as a matter of law, independent of the underlying agreement blessed by the Norwood Act. At the very least, no one would be
well advised to attempt the creation of such a standby letter of credit without first
bringing an action for declaratory relief, and the only court to consider such an
action under NOTA dismissed it on standing grounds.118
Given this reality, amending NOTA would be the only viable way to permit
standby letters of credit in extended kidney exchanges. However, doing so would
not require rejecting the basic policy against the sale of organs. One might object
that any bonding mechanism brings cash purchases of kidneys in by the back
door, raising various ethical concerns. As noted above, from the standby letter of
credit beneficiary’s point of view, the cash payment cannot be easily understood
as payment for a kidney. The same is true from the point of view of the donor
who purchases the letter and risks losing the funds held hostage in escrow should
he renege on his promise. First, under the terms of the transaction there are no
circumstances in which the reneging donor pays money directly to someone who
provided his loved one with a kidney. The only payments that he makes would
pass from him to the bank that issued the letter. Furthermore, if he carries
through on his commitment to donate a kidney, he would continue to incur the
cost of purchasing the letter, a payment that would not generate any financial
benefit for another donor. In other words, the standby letter of credit, in effect,
renders his gift more costly. One might object to this fact for a variety of reasons.
However, the fact that a gift becomes more costly does not seem to implicate
concerns about commodification.
A standby letter of credit would, of course, create a penalty in the event of
breach by a donor of his promise to make a gift. One might object that this would
have the effect of coercing someone into giving up the kidney. For several reasons, however, this objection does not justify prohibiting a donor from entering
into such a contract. First, the donor’s decision to enter into a kidney exchange
must be fully informed and voluntary. He can neither be threatened nor bribed
117. 42 U.S.C. § 274e(c)(2) (2012).
118. See Richards v. Holder, No. 13–13195–LTS, 2014 WL 2805280, at *1 (D. Mass. June 19, 2014)
(dismissing a declaratory action by someone wishing to purchase an organ who challenged the scope and
constitutionality of NOTA on standing grounds).
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into participating in the transaction. The voluntariness of the commitment ab initio should lessen concerns regarding coercion.
Second, the donor would only suffer a financial loss under the standby letter
of credit where another person relied on his good word by giving up a kidney.
This is a situation where a substantial measure of guilt attaches to a reneging
party. Unlike an enforceable promise to give the kidney, the bonding arrangement protects only a counterparty’s reliance interest and never the expectation
interest.119 Ordinarily, society is untroubled when someone is coerced because
their actions have caused another harm, as in the cases of fraud and promissory
estoppel. The same diminished concerns with coercion should govern here. Finally, the pressure on a donor in non-simultaneous kidney exchange has much
greater benefits than does pressure on a donor outside of the context of such an
exchange. This is because everyone in the downstream chain of patient-donor
dyads is dependent on the performance of upstream donors. Hence, each donation of a kidney in an extended kidney exchange benefits not only the recipient
of that kidney, but also everyone else in the exchange.
IV
PROPOSAL TWO: COUPLING FINANCIAL INCENTIVES WITH ALTRUISM IN
NEAD CHAINS
The second proposal is more dramatic than the bonding arrangement suggested above. This proposal involves relaxing the prohibition on payments to donors in the limited situation where such a payment would make a NEAD chain
possible among altruistic donors. This will, of course, will raise the hackles of
those who fear the baleful effects of commodifying kidneys. However, in this
case, relaxing the prohibition against incentivizing donors would not be tantamount to the creation of a full-fledged market in donated kidneys. Rather, the
sole reason for allowing such a payment would be that doing so would facilitate
more altruistic donations. Far from crowding out altruism, this would facilitate it.
Furthermore, as already occurs in exchanges around ovum donation, such a payment could use the language and practice of gift giving.120 This has proven a useful
strategy for managing morally- and emotionally-fraught exchanges. It can also
forestall the propagation of social understandings that commodification critics

119. See RESTATEMENT (SECOND) OF CONTRACTS § 344 (AM. LAW INST. 1981) (differentiating between the reliance and expectation interest); see also generally, L.L. Fuller & William R. Perdue, The
Reliance Interest in Contract Damages, Pt. 1, 46 YALE L. J. 52 (1936); L.L. Fuller & William R. Perdue,
The Reliance Interest in Contract Damages, Pt. 2, 46 YALE L. J. 373 (1936).
120. See Kimberly D. Krawiec, Altruism and Intermediation in the Market for Babies, 66 WASH. &
LEE L. REV. 203, 242 (2009) (“[T]he statements and screening procedures of fertility clinics indicate that
the primary motivation of egg donors should be a desire to help infertile couples and that donors whose
primary motivation is financial should be disqualified.”); Kimberly D. Krawiec, Markets, Morals, and
Limits in the Exchange of Human Eggs, 13 GEO. J.L. PUB. POL’Y 349, 354–55 (2015) (stating, for example,
that ovum donation advertising appeals to donors’ altruistic motives while also offering “handsome payment for their services.”).
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fear.
A. Why NEAD Chains Eliminate the Risk of Irreparable Harm
Recall the basic structure of a closed-loop kidney exchange described above.
To simplify, imagine that there are three patient-donor dyads: AB, CD, and EF.
B’s kidney is not a match for A but is a match for C. D is not a match for C but is
match for E. F is not a match for E but is a match for A. In this scenario, there is
a closed loop of kidney donations and the central problem is generating the trust
necessary to get the dyads to commit when the exchange extends over time. Now
imagine that there is a person, Q, who is willing to donate a kidney but does not
desire a kidney for a loved one in exchange. This is a NEAD chain. Q’s kidney is
compatible with A, who has a donor, B, whose kidney is compatible with C, who
has a donor D, whose kidney is compatible with E, who in turn has a donor F
whose kidney is compatible with G, someone on the kidney waiting list without
a donor. We can now create a NEAD chain that begins with Q’s donation to A
and ends with F’s donation to G. As a result of this chain of donations, A, D, E,
and G all receive life-saving kidneys. This scenario has two attractive features
that the closed-loop exchange lacks. First, it results in one additional person receiving a kidney, namely G.121 Second, it eliminates the risk to the first mover
involved in a closed-loop kidney exchange.
To see why Q’s donation eliminates this risk, recall the structure of the counterparty risk. In a closed-loop kidney exchange, the first donor takes the chance
that she will donate a kidney but receive nothing for her patient in return because
a downstream donor reneges on his promise to give a kidney. The entire transaction depends on high levels of trust by the first mover in the extended kidney
exchange chain. In the NEAD chain made possible by Q’s donation, however, Q
is not part of a patient-donor dyad. Thus, he takes on no risk. Rather, he enters
the transaction with the understanding that he will not be receiving a kidney in
exchange for his donation. Every subsequent donor in the NEAD chain, however, can receive a kidney for his patient prior to donating. In short, Q is the
magic catalyst who solves the trust problem that could otherwise bedevil nonsimultaneous exchanges.
Where might we find Q? One possibility is that Q is that exceedingly rare
individual who desires to gratuitously donate a kidney to a stranger. Such donors,
however, make up less than 1% of the current supply of kidneys. Indeed, when a
person gratuitously offers to donate a kidney to a stranger, most transplant professionals try to talk the person out of making the donation.122 In the past, the
121. One might ask why G should get the kidney from F, since F’s donation is not necessary for E—
the patient in the EF patient-donor dyad—to receive a kidney. The answer is that because E has a willing
donor, F, who will put a kidney into the system, E gets off of the waiting list and into a transplant operating room. G gets the kidney from F because F’s kidney is simply the next available free kidney in the
system, for which G is a match and G has advanced to first place on the waiting list.
122. See Rebecca P. Winsett et al., Perceptions of the Donation Process from Adult-to-adult Living
Liver Donors, 13 PROG. TRANSPLANT. 123, 125 (2003) (stating that doctors discouraged donors from
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mere fact that someone was willing to make such an offer was seen by some doctors as prima facie evidence of mental illness.123 Such donors are simply not a
viable option for substantially increasing the number of kidneys available in the
system. To be sure, if the 180 or so individuals each year who are willing to donate
kidneys to strangers could be used in NEAD chains, their generosity could be
leveraged. But, desirable as this is, it would not make a significant impact on the
availability of kidneys.
B. Paying Initial Donors in NEAD Chains
This paper proposes that Q be found by offering cash payments or some other
form of valuable financial incentive to those who are willing to donate a kidney
to be used to begin a NEAD chain.124 This is not the same thing as calling for a
free market in kidneys; however, this proposal would require a change in current
law. It is worth noting that the prohibition on bargaining for kidneys has already
been relaxed. In 2005, Congress explicitly amended NOTA with the Norwood
Act in order to allow for paired organ exchanges.125 Such exchanges involve the
exchange of a kidney, not for cash, but for another kidney. Nevertheless, under
the original language of NOTA, the receipt of the kidney in exchange for an organ donation would surely constitute “valuable consideration.”126 The 1984 law
was amended to allow such kidney-for-kidney sales. The logic behind the Norwood Act was that there were opportunities for altruistic donations that were
being wasted because of a tissue mismatch between donor and patient. Accordingly, Congress allowed the exchange of donated organs in order to facilitate
these altruistic acts.
Two things are worth noting about this decision. First, it unambiguously allows organ trade. It simply limits the medium of exchange to a system of pure
barter. Second, the system of barter authorized by the Norwood Act entwines
bargain with altruistic donation. Limiting exchange to the trade of altruistically
donated organs ensures that organ exchange will never be a nakedly-commercial
transaction. The market in traded organs is only possible because the trades are
embedded in a broader economy of gift giving. The following proposal would
involve a similar entanglement of incentives and altruism.
If NOTA were amended to allow payment to first-moving donors in a NEAD

donating their organs).
123. See Robert M. Sade & Andrea D. Boan, The Paradox of the Dead Donor Rule: Increasing Death
of the Waiting List, 14 AM. J. BIOETH. 21, 22 (2014) (“Good Samaritan donation . . . was once considered
prima facie evidence of mental illness.”).
124. See Stephen J. Choi et al., Altruism Exchanges and the Kidney Shortage, 77 LAW & CONTEMP.
PROBS., no. 3, 2014, at 289, 299 (arguing that one should be able to pay for kidneys with gifts to a charity
of the donor’s choice). Polling data suggests that there is widespread support for non-cash incentives for
organ donation. See Hensley, supra note 34.
125. Charlie W. Norwood Living Organ Donation Act, Pub. L. No. 110-144, 121 Stat. 1813 (2007)
(codified at 42 U.S.C. §§ 273b, 274e (2006 & Supp. IV 2011)).
126. 42 U.S.C. § 274e(a) (2012).
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chain, the same two conditions would be met. First, the exchange of organs in a
trade would be authorized. However, one trade would be allowed to occur in
exchange for cash or other financial incentives, rather than an organ to be donated to a loved one. Second, the exchange would not be a naked commercial
transaction. Rather, the proposal would allow direct financial incentives for donation—but only in cases where the donation would then allow an extended series of altruistic donations. In other words, the “market” in traded organs would
remain embedded in a broader economy of gift giving. The original logic of the
Norwood Act was that without trade, there are many altruistic donations that
simply will not occur. The same is true of this proposal. In particular, long chains
of extended kidney donations are impossible without very high levels of mutual
trust among the gift-givers. Without this trust, the gifts simply will not happen,
and opportunities for altruistic donations will be wasted. Just as the Norwood Act
allowed limited trading to catalyze these donations, NOTA should be amended
to allow an initial sale to facilitate donations.
Such a change in the law would not lead to the wholesale commodification of
human organs. It would maintain the social view that organ donation is primarily
a matter of gift. Indeed, the vast majority of all kidney transplants would remain
gifts. Furthermore, even the initial sale of organs would itself be encased in a
social understanding that still relied heavily on the idea of gift. This could be done
in two ways. First, the amount paid for a kidney donation could be limited. The
goal of the proposal is not to create commerce in kidneys with a market clearing
price; rather, it is to increase the number of undirected donations by offering a
financial incentive. Setting the amount below a market clearing price would, of
course, ensure that a chronic gap in the supply of needed kidneys remains. However, doing so would also inhibit the emergence of a robust market for kidney
donations, thus allaying fears of commodification, while still marginally increasing the supply of kidneys.
Furthermore, there is no reason that a financial incentive must be structured
as a straightforward purchase. Instead, for example, the payment could be made
as part of a prize awarded by a foundation. A study by Muriel Niederle and Alvin
Roth found that people were significantly more likely to support payments when
they were structured as an award given by a private foundation rather than, say,
as a payment by the government.127 Likewise, incentives do not have to take the
form of cash payments. For example, NEAD donors could be rewarded with
health insurance or educational vouchers for themselves or for loved ones.
Second, a kidney exchange regime could appeal to the donor’s own sense of
generosity. People usually act from mixed motives. The incentivized donor that
this article’s proposal imagines could be motivated by a similar mix of compensation and altruism. The donation of their kidney would be more than a sale: it
would be a gift, one that makes possible the gifts of others whose desire is to
127. See generally Muriel Niederle & Alvin E. Roth, Philanthropically Funded Heroism Awards for
Kidney Donors?, 77 LAW & CONTEMP. PROBS., no. 3, 2014, at 131.
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rescue their loved ones. Such an appeal to the donor’s own sense of generosity
could motivate donations that might not occur otherwise. Such a sense of generosity is by no means incompatible with paid compensation. Many of those in the
caring professions—doctors, nurses, social workers, therapists, teachers, and the
like—are genuinely motivated by a desire to help other people. They see their
professional activities as advancing an effort to make the lives of others better.
This motivation coexists with a regime in which they are paid for their services.
By emphasizing the way in which a compensated donor’s act facilitates altruistic
giving and the life-saving transplants for those who do not receive her kidney, the
supposedly pernicious social meanings that worry critics of commodification can
be avoided.
There are examples of such mixed understandings of compensated donations
of human tissues. Some ovum donors, for example, report that they are motivated
by purely mercenary considerations.128 Many, however, insist that in addition to
the money made by donating their eggs, they are genuinely moved by the plight
of childless couples and see themselves as assisting such couples.129 Both fertility
clinics and the couples themselves emphasize this understanding of egg donation,
styling payments as “thank-you gifts.”130 Anthropologists have long recognized
that gift giving is never purely altruistic, but operates in a moral economy of reciprocity in which a gift creates some unspecified future obligation.131 Compensated ovum donation does not exist in the pure economy of gift, but it also is
something more than the bare economy of commercial exchange. Rather, it is a
hybrid of the two approaches—albeit one that leans heavily towards commerce.132
For those whose concerns with the sale of organs center on commodification
and the social meaning that exchange could impart to human bodies, the language of gift in ovum exchanges is not without value. Far from being meaningless
rhetorical hypocrisy, it is an effort to respond to precisely the concerns that such
critiques raise; namely, the social meaning of the exchange. Experience teaches
that the simple dichotomy of gift and bargain does not adequately capture the
complexity and nuance of which social meanings around transfers are capable.
Ultimately, market exchange does not have a single, stable, or self-evident meaning. This is a fact that merchants have long understood, even if only implicitly.
Hence, the bewildering variety of rhetorical envelopes in which our society wraps
trade—from the impersonal order placed in a pure commodity market, to the
doctors or lawyers with whom we discuss our most intimate affairs, to the soldiers
or fire fighters who sell their labor but are also valorized for heroism and self128.
129.
130.
131.

See Krawiec, supra note 120, at 355 (some egg donors are “in it for the money”).
See id. at 355 (some egg donors donate in part to help infertile women conceive).
Id. at 355 (egg banks encourage recipients to send “thank you . . . gifts” to donors).
See MARCEL MAUSS, THE GIFT: THE FORM AND REASON FOR EXCHANGE IN ARCHAIC
SOCIETIES xi (2000).
132. See HEALY, supra note 48, at 44 (stating that donor procurement systems have “industrialized
altruism”).
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sacrifice. The language of gift around ovum donation is an effort to construct a
social meaning in which reproductive capacity is not reduced to a mere commodity. It provides a useful model for negotiating other morally- and emotionallyfraught exchanges.
Finally, there is the persistent concern that compensated kidney donations
would harm the poor, who would disproportionately be among those who would
give their organs in exchange for money. That is unfounded for two reasons. First,
it is by no means obvious that the poor would be primarily the ones to donate.
Similar concerns have been raised in the past about surrogate pregnancy and paid
ovum donation. However, experience with these markets in the United States
indicates that suppliers of ova, and those who undertake surrogate pregnancy on
the whole, do not come from the ranks of the impoverished.133
Second, concerns with economic exploitation could be alleviated by testing
donors. For example, regulation could prohibit paid compensation of donors
whose income is below the federal poverty line. Some might object that such a
policy would harm the poor by depriving them of a source of income. However,
the purpose of compensated donation is to facilitate NEAD chains, not to improve the lot of the poor. A more telling objection is that means-testing of donors
would limit the supply that would otherwise be available if donors were not
means-tested. This is possible. However, for the reasons stated above, this is not
necessarily the case. Even if it were, given the moral and political concerns regarding compensated donation, a supply-limiting concession seems preferable to
the current system where no additional organs are available to facilitate NEAD
chains that will not otherwise occur.
V
CONCLUSION
There is little to be gained by polarizing the debate regarding the supply of
kidneys for transplant with charged statements about the merits of altruism and
markets. A full-fledged market in human organs in the United States is unlikely.
However, this political reality does not change the medical reality that each year,
thousands of people die awaiting kidney transplants. There is already a well-entrenched political and legal consensus in favor of allowing paired kidney donations. Such organ exchanges can be extended beyond bilateral trades into extended chains of donations, which have the potential to greatly increase the
number of organs available for transplant. As such chains become longer, they
hold hope for providing not simply more transplants, but transplants for patients
for whom it is particularly difficult to find a compatible donor. However, such
exchanges require high levels of trust among donors. Without such trust, many
life-saving exchanges simply will not happen.

133. See generally Busby & Vun, supra note 53.
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This article offers two proposals for facilitating such trust. The first is for donors to use standby letters of credit. Such letters would not involve the direct
purchase of kidneys. Rather, they would serve primarily to provide increased—
although admittedly far from perfect—assurances of performance and—again
admittedly imperfect—insurance against counter-party risk. Their moral logic is
ultimately that of oath-keeping, not sale. They also have the advantage of employing a well-developed legal form, which is designed to overcome practical difficulties of enforcement and counterparty risk, and which has been honed over
centuries of commercial practice. The second proposal is to allow for limited financial incentives to be paid to donors who are willing to make undirected donations when their donations catalyze a NEAD chain among altruistic donors. The
presence of a single gratuitous donor on the front end of a NEAD chain can eliminate exposure to the risk of irreparable harm down the chain. Such financial incentives would represent, at most, an imperfect commodification of kidneys. Current law already recognizes the legitimacy of such imperfect commodification by
allowing kidneys to be traded for other kidneys. Like those uncontroversial organ
swaps, paid donations for initial donors in extended exchanges would nest bargains in a network of altruistic acts and donations. This would effectively increase
the number of life-saving transplants without creating a full-fledged market in
human organs.

